Huina Zhang

university of rochester

H指数:29

被引数:3,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Concurrent MYC-Amplified Secondary Angiosarcoma and Recurrent Carcinoma in the Breast: A Rare Presentation With Unique Clinical Features and Distinct MYC Amplification Patterns

并发MYC扩增的继发性血管肉瘤和复发性癌在乳腺：一种具有独特临床特征和不同MYC扩增模式的罕见表现

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

IF1

2026-05-010

PRE

Sex cord-like elements in Müllerian lesions: Report of two rare cases and review of the literature

Müllerian病变中的性索样成分：两例罕见病例报告及文献综述

Human Pathology Reports

IF0.4

2025-10-010

OAAI

Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study

不同观察者间一致性及接近导管原位癌的导管内上皮非典型增生组织学分析：一项多中心研究

AMERICAN JOURNAL OF CLINICAL PATHOLOGY

IF1.9

2025-09-010

PRE

Smartphone video-based early diagnosis of blepharospasm using dual cross-attention modeling enhanced by facial pose estimation

基于智能手机视频的双交叉注意力建模及面部姿态估计增强的眨眼痉挛早期诊断

npj Digital Medicine

IF15.1

2025-08-050

OAAI

Tumor infiltrating lymphocytes in breast cancer: A narrative review with focus on analytic validity, clinical validity, and clinical utility

乳腺癌中的肿瘤浸润淋巴细胞：一篇聚焦于分析有效性、临床有效性和临床应用价值的叙事性综述

Human Pathology

IF2.6

2025-07-020

PRE

Estrogen receptor-low positive breast cancer: Historical perspective and recent advancements

雌激素受体低阳性乳腺癌：历史回顾与最新进展

Human Pathology

IF2.6

2025-05-270

PRE

Comprehensive pan-cancer analysis reveals CD70 as a promising therapeutic target and biomarker in clear cell renal cell carcinoma

综合泛癌分析揭示CD70是透明细胞肾细胞癌中一个有潜力的治疗靶点和生物标志物

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2025-05-010

PRE

Clinical Effect of Pembrolizumab in Uterine Serous Carcinoma May be Affected by HER2 Status and Related Genetic Landscape

LABORATORY INVESTIGATION

IF4.2

2025-03-010

PRE

Impact of HER2 Scoring Criteria on Potential Eligibility for T-DXd Therapy in Uterine Serous Carcinoma

LABORATORY INVESTIGATION

IF4.2

2025-03-010

PRE

HER2-Targeted Treatment in Uterine Serous Carcinoma: Real-World Trastuzumab Use and HER2-Low Expression

LABORATORY INVESTIGATION

IF4.2

2025-03-010

PRE

Breast Cancer With HER2 Immunohistochemical Score 2 and Average HER2 Signals/Cell 6 or More and HER2/CEP17 Ratio Less Than 2 ('ISH Group 3'): A Multiinstitutional Cohort Analysis Emphasizing Outcome and Molecular Subtype

MODERN PATHOLOGY

IF5.5

2024-08-010

PRE

Overall Survival and Disease Interval Among Breast Cancer Subtypes in Patients with Brain Metastasis

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Associations of Single Versus Multiple Human Papillomavirus Infections With the Prevalence of Cervical Intraepithelial Neoplasia 2/3 and Squamous Cell Carcinoma Lesions: Human Papillomavirus TypeeSpecific Attribution

LABORATORY INVESTIGATION

IF4.2

2024-04-016

OAAI

HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls

HISTOPATHOLOGY

IF4.1

2024-03-059

PRE

In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistochemistry

LABORATORY INVESTIGATION

IF4.2

2024-03-011

PRE

Correlation of HER2 Protein Level With mRNA Level Quantified by RNAscope in Breast Cancer

MODERN PATHOLOGY

IF5.5

2024-02-015

PRE

Single and Multiple High-Risk Human Papillomavirus Infections in Histopathologically Confirmed Cervical Squamous Lesions: Incidences, Distribution, and Associated Detection Rates for Precancerous and Cancerous Lesions

LABORATORY INVESTIGATION

IF4.2

2023-11-015

PRE

Sophisticated Magneto-Mechanical Actuation Promotes In Situ Stem Cell Assembly and Chondrogenesis for Treating Osteoarthritis

ACS NANO

IF16

2023-10-2011

PRE

Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients

HER2超低位乳腺癌与HER2无效或HER2低位乳腺癌不同吗？对1363患者的研究

BREAST CANCER RESEARCH AND TREATMENT

IF3

2023-08-286

OAAI

Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy (vol 32, pg 807, 2019)

MODERN PATHOLOGY

IF5.5

2023-08-011

OAAI

Huina Zhang

个人简介

教育背景

工作经历

荣誉奖项

研究方向